ProCE Banner Activity

Long-Acting PrEP at AIDS 2024: Perspectives From Africa

Conference Coverage
Clinical Thought

Long-acting PrEP may help overcome important barriers associated with adherence and persistence to daily oral PrEP. Read on to learn how studies in Africa, presented at the AIDS 2024 conference, can inform widespread implementation of long-acting PrEP in other regions of the world.

Released: August 20, 2024

Expiration: August 19, 2025

Share

Faculty

Kenneth Ngure

Kenneth Ngure, MPH, MSc, PhD

Associate Professor
School of Public Health, JKUAT
Nairobi, Kenya
Affiliate Associate Professor
Department of Global Health
University of Washington
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Faculty Disclosure

Primary Author

Kenneth Ngure, MPH, MSc, PhD

Associate Professor
School of Public Health, JKUAT
Nairobi, Kenya
Affiliate Associate Professor
Department of Global Health
University of Washington
Seattle, Washington

Kenneth Ngure, MPH, MSc, PhD, has no relevant financial relationships to disclose.

Presenter

Angela Davies, MD

Assistant Professor of Medicine
UC Davis Cancer Center
Sacramento, CA